Artificial intelligence as medical device in radiology in 2025: the regulatory scenario in the EU, USA, and China.
PMID: 41832928 ·
F, i, l, i, p, p, o, , P, e, s, a, p, a, n, e, ;, , C, a, r, l, o, , D, e, , C, e, c, c, o, ;, , H, a, o, , W, a, n, g, ;, , M, a, t, h, i, a, s, , K, , H, a, u, g, l, i, d, ;, , F, r, a, n, c, e, s, c, o, , S, a, r, d, a, n, e, l, l, i
Publicidad
Resumen
In the last decade, advanced AI methods were applied to radiology, providing tools for clinical practice. Regulations across countries are a relevant topic, considering that AI tools must be regarded as medical devices. We describe the regulatory scenarios in the EU, USA, and China. For the EU, we considered the 2017 Medical Device Regulation, including AI tools as "active" medical devices, the 2018 General Data Protection Regulation, protecting data privacy, and the risk-based approach by the 2
Publicidad
Fuente oficial
Ver en PubMed →Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.